Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Abstract Text:

G V Papatheodoridis,E Hadziyannis,E Tsochatzis,N Chrysanthos,A Georgiou,G Kafiri,S Manolakopoulos,D G Tiniakos,I Giannousis,E K Manesis,A J Archimandritis,

BACKGROUND AND AIMS: In chronic hepatitis C and non-alcoholic fatty liver disease, apoptotic caspases are activated in liver, and serum caspase activity has been suggested as a sensitive marker of early liver injury. An investigation was carried out into whether the serum levels of caspase-generated fragments of cytokeratin-18 (CK-18) are associated with the severity of liver lesions in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B virus (HBV) infection. Patients/ METHODS: CK-18 fragment serum levels were determined in 115 treatment-naive, consecutive HBV patients and 30 healthy controls. Hepatic-expression of CK-18 fragments was evaluated by immunocytochemistry in chronic hepatitis B patients. RESULTS: CK-18 fragment levels (U/l) were significantly lower in healthy controls (mean (SD), 154 (31)) than in 53 inactive carriers (172 (24), p = 0.003) and in 62 chronic hepatitis B patients (474 (488), p<0.001). The receiver operating characteristic curve showed excellent diagnostic accuracy (c-statistic: 0.87) for differentiating inactive carriers from chronic hepatitis B patients. A CK-18 fragment cut-off level of 240 U/l gave a sensitivity of 60%, and a specificity and positive predictive value of 100% for chronic hepatitis B diagnosis. CK-18 fragment levels were also lower in inactive carriers than in 16 chronic hepatitis B patients with transiently normal alanine aminotransferase (ALT; 327 (256), p = 0.001), offering good accuracy for such a differentiation (c-statistic: 0.78). In chronic hepatitis B patients, serum CK-18 fragments correlated positively with ALT/aspartate aminotransferase (AST), viraemia, grading score and their immunohistochemical hepatic expression, and negatively with platelet counts, but not with fibrosis or steatosis severity. CONCLUSIONS: Serum apoptotic caspase activity is strongly associated with the presence of liver injury in patients with HBeAg-negative chronic HBV infection. CK-18 fragment levels seem to be a very useful marker for differentiation between the inactive HBV carrier state and HBeAg-negative chronic hepatitis B, but not for estimation of the severity of liver histological lesions among HBeAg-negative chronic hepatitis B patients.

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Publishing Authors By Initials

GV Papatheodoridis,E Hadziyannis,E Tsochatzis,N Chrysanthos,A Georgiou,G Kafiri,S Manolakopoulos,DG Tiniakos,I Giannousis,EK Manesis,AJ Archimandritis,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Gut

VOLUME: 57

Page Numbers: 500-6

Journal Abbreviation:

ISSN: 1458-3288

DAY: 19

MONTH: 11

YEAR: 2007

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2985108

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.

AFFILIATION: Second Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital of Athens, 114 Vas. Sophias Ave., 115 27 Athens, Greece. gepapath@med.uoa.gr

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Gut

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection Related Publications

• A 70-year-old stock-breeder with tricuspid valve and defibrillator lead brucella endocarditis.
• Adipokines and insulin resistance in chronic hepatitis C.
• Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation.
• An extranodal NK/T cell lymphoma, nasal type, with specific immunophenotypic and genotypic features.
• Angioimmunoblastic T-cell lymphoma-associated arthritis: case report and literature review.
• Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications.
• Changes of liver and muscle enzymes activity in patients with rigor.
• Epidemiological evidence for the non-random clustering of the components of the metabolic syndrome: multicentre study of the Mediterranean Group for the Study of Diabetes.
• Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
• Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
• Myelodysplastic syndrome presenting as acquired ichthyosis.
• Performance Characteristics of Microparticle Enzyme and Chemiluminescence Immunoassays for Measurement of Anti-HBc Immunoglobulin M in Sera of Patients with HBeAg-Negative Chronic Hepatitis B Virus Infection.
• Pseudohyperkalemia in serum: a new insight into an old phenomenon.
• Sensorineural hearing loss complicating severe rickettsial diseases: report of two cases.
• Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity.
• Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
• Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency.
• Systemic Vasculitis With Gastrointestinal Involvement in an HIV-Infected Adult.
• Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.
• Usefulness of enzyme-linked immunosorbent assay (elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Addendum.
• Usefulness of enzyme-linked immunospot assay (elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.